Author profile
David B. Miller, MD, FRCPC
Diabetes is a chronic metabolic disease that is becoming more common in British Columbia, with predicted prevalence rates rising from 8.3% in 2013 to 10.3% in 2020.[1] The complications of diabetes contribute... Read More
British Columbia’s health authorities have formed a single BC Health Authorities Pharmacy and Therapeutics (BCHA P&T) Committee to make recommendations regarding drugs that will become or not become part of your... Read More
A recent publication of the Therapeutics Initiative (TI) of British Columbia, “Do statins have a role in primary prevention?” suggested that statin medications (properly called HMG-CoA reductase inhibitors) may do more... Read More